Katie Brock
About Katie Brock
Katie Brock serves as the Associate Director at Kite Pharma in Stockley Park, England, since 2021. She has extensive experience in clinical trial management, having held various roles at notable companies including BioMarin, Bristol-Myers Squibb, and GlaxoSmithKline.
Work at Kite Pharma
Katie Brock has been serving as Associate Director at Kite Pharma since 2021. Her tenure at the company spans three years, during which she has contributed to various projects in Stockley Park, England. Prior to her current role, she held multiple positions at Kite Pharma, including Clinical Program Manager from 2019 to 2021 and Study Manager from 2017 to 2019. Her experience at Kite Pharma highlights her expertise in clinical trial management and program oversight.
Previous Experience in Clinical Trials
Katie Brock has extensive experience in clinical trials, having worked in various roles across several organizations. She served as a Contract Clinical Trial Manager at BioMarin from 2013 to 2015. Additionally, she worked at Bristol-Myers Squibb as a Senior Clinical Scientist from 1990 to 1998. Her career also includes positions at OSI Pharmaceuticals as Clinical Project Manager and at GlaxoSmithKline as Contract Clinical Study Manager, showcasing her long-standing involvement in the clinical research field.
Education and Expertise
Katie Brock studied at King's College London, where she earned a degree in Biochemistry and Physiology, achieving a 2:1 classification. Her educational background provides a solid foundation for her career in clinical research and trial management. This academic experience has likely contributed to her expertise in overseeing complex clinical programs and ensuring compliance with research governance.
Background in Clinical Research
Katie Brock's background in clinical research includes a variety of roles that have shaped her career. She worked as a Consultant for Clinical Trials & Research Governance at the University of Oxford in 2011. Her experience also includes a position as Senior Clinical Study Manager at Oxford BioMedica from 2015 to 2017. This diverse background reflects her comprehensive understanding of clinical trial processes and regulatory requirements.